Scarica l'app Stockscreener
83.45
2.07%
1.81
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EW Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$81.64
Aprire:
$80.87
Volume 24 ore:
2.31M
Relative Volume:
0.58
Capitalizzazione di mercato:
$48.48B
Reddito:
$6.07B
Utile/perdita netta:
$1.06B
Rapporto P/E:
46.20
EPS:
1.8063
Flusso di cassa netto:
$1.34B
1 W Prestazione:
-4.42%
1M Prestazione:
+8.50%
6M Prestazione:
+4.42%
1 anno Prestazione:
+18.48%
Intervallo 1D:
$80.54
$83.73
Intervallo di 1 settimana:
$80.50
$86.56
Portata 52W:
$65.94
$87.89
Edwards Lifesciences Corp Stock (EW) Company Profile
Nome
Edwards Lifesciences Corp
Settore
Industria
Telefono
(949) 250-2500
Indirizzo
ONE EDWARDS WAY, IRVINE, CA
Compare EW vs ABT, SYK, MDT, BSX
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
83.47 | 47.42B | 6.07B | 1.06B | 1.34B | 1.8063 |
|
ABT
Abbott Laboratories
|
111.90 | 190.38B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
362.65 | 139.51B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
90.79 | 116.71B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
71.70 | 105.88B | 20.08B | 2.89B | 3.66B | 1.9391 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-12-18 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-11-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-10-29 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2025-10-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-10-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-29 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-04-24 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Stifel | Hold → Buy |
| 2025-01-16 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-11 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-09-18 | Downgrade | Jefferies | Buy → Hold |
| 2024-07-31 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-07-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | Downgrade | TD Cowen | Buy → Hold |
| 2024-07-25 | Downgrade | Truist | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-05-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-05-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-03-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-02-02 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2023-11-28 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-03-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | Downgrade | Bernstein | Outperform → Underperform |
| 2023-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | Downgrade | Stifel | Buy → Hold |
| 2022-10-28 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-10-26 | Iniziato | Mizuho | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-29 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-03-16 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-27 | Reiterato | Citigroup | Buy |
| 2022-01-27 | Reiterato | Evercore ISI | Outperform |
| 2022-01-27 | Reiterato | Raymond James | Outperform |
| 2022-01-27 | Reiterato | Stifel | Buy |
| 2022-01-27 | Reiterato | UBS | Neutral |
| 2021-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-12-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | Reiterato | Canaccord Genuity | Buy |
| 2021-07-30 | Reiterato | Deutsche Bank | Hold |
| 2021-07-30 | Reiterato | Jefferies | Buy |
| 2021-07-30 | Reiterato | Morgan Stanley | Overweight |
| 2021-07-30 | Reiterato | Oppenheimer | Outperform |
| 2021-07-30 | Reiterato | Stifel | Buy |
| 2021-07-30 | Reiterato | UBS | Neutral |
| 2021-07-30 | Reiterato | Wells Fargo | Equal Weight |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Neutral |
| 2021-04-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-11 | Reiterato | Canaccord Genuity | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Underperform |
| 2020-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Neutral |
| 2020-01-10 | Iniziato | Oppenheimer | Outperform |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-10-24 | Reiterato | Canaccord Genuity | Buy |
| 2019-09-23 | Iniziato | Piper Jaffray | Overweight |
| 2019-07-24 | Reiterato | BofA/Merrill | Buy |
| 2019-03-18 | Reiterato | Canaccord Genuity | Buy |
| 2019-01-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Hold |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-10-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | Downgrade | Guggenheim | Buy → Neutral |
Mostra tutto
Edwards Lifesciences Corp Borsa (EW) Ultime notizie
Niranjan Pai joins Edwards Lifesciences as Director-Government Affairs - Exchange4Media
Inceptionr LLC Makes New $1.61 Million Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Acquired by Russell Investments Group Ltd. - MarketBeat
Rathbones Group PLC Has $6.84 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
Rhenman & Partners Asset Management AB Has $12.05 Million Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Blair William & Co. IL Has $28.96 Million Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
How Edwards Lifesciences Corporation stock performs during Fed tightening cyclesJuly 2025 Weekly Recap & Consistent Profit Alerts - Naître et grandir
Edwards Lifesciences Corp (EW) Trading Down 3.41% on Mar 6 - GuruFocus
Fisher Asset Management LLC Cuts Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Edwards Lifesciences Corporation $EW Shares Acquired by Elo Mutual Pension Insurance Co - MarketBeat
Edwards Lifesciences Corp (EW) Stock Price Down 3.76% on Mar 3 - GuruFocus
Edwards Lifesciences (NYSE:EW) VP Sells $974,446.20 in Stock - MarketBeat
Edwards Lifesciences Corp Officer Sells Shares - TradingView
Edwards Lifesciences at TD Cowen Conference: Strategic Growth and Innovation - Investing.com
Why Investors Are Eyeing Edwards Lifesciences Corp (EW): The Key - GuruFocus
Intech Investment Management LLC Increases Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Huntington National Bank Sells 14,023 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Erste Asset Management GmbH Lowers Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Hits Day High with Strong 3% Intraday Surge - Markets Mojo
TD Asset Management Inc Sells 12,562 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Insider Sold Shares Worth $2,012,076, According to a Recent SEC Filing - marketscreener.com
Edwards Lifesciences CVP Bobo sells $2m in stock - Investing.com
Edwards Lifesciences (NYSE: EW) VP sells 24,000 common shares - Stock Titan
Edwards Lifesciences Corp Officer Sells 24,000 Shares - TradingView
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
[144] Edwards Lifesciences Corp SEC Filing - Stock Titan
Edwards Lifesciences at Citi’s MedTech Day: Optimism in Growth Strategies - Investing.com
10 Health Care Stocks Whale Activity In Today's Session - Benzinga
Edwards Lifesciences plans to reach 2M underserved heart patients by 2030 - Stock Titan
How The Edwards Lifesciences (EW) Investment Story Is Shifting After Mixed Analyst Revisions - Yahoo Finance
Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insigh - GuruFocus
Edwards Lifesciences Hits Day High with Strong 3.28% Intraday Surge - Markets Mojo
Edwards Lifesciences Hits Day High with Strong 3.33% Intraday Surge - Markets Mojo
Edwards Lifesciences Opens with 3.2% Gain, Outpacing S&P 500's 0.69% Increase - Markets Mojo
Edwards Lifesciences Stock Climbs 1.21% on Stronger Revenue, $0.35 Billion Trading Volume Ranks 387th for the Day - Bitget
Zacks Industry Outlook Highlights Intuitive Surgical, Edwards Lifesciences and Electromed - Yahoo Finance
NEW SURVEY BY EDWARDS LIFESCIENCES UNCOVERS JUST HOW MUCH AMERICANS KNOW ABOUT THEIR HEART HEALTH - Yahoo Finance
Daiwa Securities Adjusts Price Target on Edwards Lifesciences to $98 From $99, Maintains Buy Rating - marketscreener.com
Here is Why Edwards Lifesciences Corporation (EW) Looks Attractive - Insider Monkey
Edwards Lifesciences (EW) SVP reports 176-share tax-withholding disposition - Stock Titan
Edwards Lifesciences Corp (EW)'s Winning Formula: Financial Metr - GuruFocus
Equitable Trust Co. Sells 15,075 Shares of Edwards Lifesciences Corporation $EW - Defense World
Cardiac Valve Market 20262035 Major Key Players: Edwards - openPR.com
Will Edwards Lifesciences Corporation stock deliver long term returnsTrade Analysis Summary & Proven Capital Preservation Methods - mfd.ru
Edwards Lifesciences Stock at $78: Here’s the Analysts’ Bull Case Scenario - TIKR.com
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing - The Motley Fool
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences - marketscreener.com
First National Bank of Omaha Purchases New Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Alberta Investment Management Corp Buys Shares of 68,300 Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences advances smart surgery monitoring with completed SMART TRENDS study - MSN
Edwards Lifesciences Corp Azioni (EW) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):